2 completed, 1 recruiting. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Cooperative Weichteilsarkom Study Group: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision) Peptide vaccine IPX - Ewing Sarcoma, Rhabdomyosarcoma | Phase 1 / Phase 2 | Recruiting | University Hospital Tuebingen | 30 | 2023-09-19 | 2026-05-04 |
| Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma trofosfamide, idarubicin, etoposide - Soft Tissue Sarcoma | Phase 3 | Completed | University Hospital Tuebingen | 195 | 2009-07-01 | 2022-11-08 |
| a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4 Topotecan, Carboplatin - Sarcoma, Soft Tissue | Phase 2 | Completed | Cooperative Weichteilsarkom Study Group | 90 | 2005-01-01 | 2009-04-02 |
Rhabdomyosarcoma (2) · Sarcoma (2) · Sarcoma, Synovial (2) · Sarcoma, Ewing (1)
Carboplatin (1) · Etoposide (1) · Idarubicin (1) · Topotecan (1) · trofosfamide (1)
Germany (3) · Austria (1) · Poland (1) · Sweden (1) · Switzerland (1)
Ewa Koscielniak, MD (1) · Martin Ebinger, Prof. Dr. (1) · Monika Sparber Sauer, MD (1) · Thomas Klingebiel, MD (1) · Thomas Klingebiel, Prof. Dr. (1)